Sophia Saifee, MD
Internal Medicine · Douglasville, GANPI 1851543086
Payments from drug & device makers
Across 210 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$517
- Pfizer$361
- AstraZeneca$348
- Novartis$344
- Abbott$301
- Astellas Pharma US Inc$257
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,873100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $517 |
| Pfizer | 19 | $361 |
| AstraZeneca | 20 | $348 |
| Novartis | 17 | $344 |
| Abbott | 15 | $301 |
| Astellas Pharma US Inc | 11 | $257 |
| Lilly USA, LLC | 12 | $213 |
| AbbVie | 11 | $194 |
| Amgen | 11 | $175 |
| GSK | 5 | $111 |
| Exact Sciences | 6 | $109 |
| Dexcom, Inc. | 6 | $99 |
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| Merck | 6 | $96 |
| Boehringer Ingelheim | 5 | $94 |
| Bayer | 4 | $89 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $58 |
| Antares Pharma, Inc. | 3 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Verity Pharmaceuticals Inc. | 2 | $34 |
| Globus Medical | 1 | $26 |
| Johnson & Johnson | 1 | $26 |
| Dynavax Technologies Corporation | 1 | $24 |
| Shield Therapeutics Inc | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Philips North America LLC | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Optinose US, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Gilead | 1 | $12 |
How this compares
$3,873 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 30 | $471 |
| Atorvastatin Calcium | 57 | $397 |
| Amlodipine Besylate | 43 | $259 |
| Levothyroxine Sodium | 24 | $245 |
| Losartan Potassium | 36 | $240 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 11 | $201 |
| Omeprazole | 19 | $195 |
| Pantoprazole Sodium | 15 | $154 |
| Pravastatin Sodium | 17 | $140 |
| Metoprolol Succinate | 13 | $115 |
| Hydrochlorothiazide | 24 | $115 |
| Metformin Hcl | 19 | $91 |
| Lisinopril | 20 | $85 |
| Carvedilol | 15 | $68 |
| Metoprolol Tartrate | 13 | $33 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Douglasville
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
- Charles KempAlbany$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.